A progestogen, also referred to as a progestagen, gestagen, or gestogen, is a type of medication which produces effects similar to those of the natural female sex hormone progesterone in the body. A progestin is a synthetic progestogen. Progestogens are used most commonly in hormonal birth control and menopausal hormone therapy.
They can also be used in the treatment of gynecological conditions, to support fertility and pregnancy, to lower sex hormone levels for various purposes, and for other indications.
This report aims to provide a comprehensive presentation of the global market for Gynecological Progestin Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gynecological Progestin Drugs. This report contains market size and forecasts of Gynecological Progestin Drugs in global, including the following market information:
Global Gynecological Progestin Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Gynecological Progestin Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Gynecological Progestin Drugs companies in 2022 (%)
The global Gynecological Progestin Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Progesterone Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gynecological Progestin Drugs include Merck, Teva Generics, Besins Healthcare, Virtus Pharmaceuticals, LLC, BionPharma, Aquatic Remedies, Zhejiang Xianju Pharmaceutical, Zhejiang Aisheng Pharmaceutical and Zhejiang Medicine, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gynecological Progestin Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gynecological Progestin Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gynecological Progestin Drugs Market Segment Percentages, by Type, 2022 (%)
Progesterone
Dydrogesterone
Others
Global Gynecological Progestin Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gynecological Progestin Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Gynecological Progestin Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gynecological Progestin Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gynecological Progestin Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Gynecological Progestin Drugs revenues share in global market, 2022 (%)
Key companies Gynecological Progestin Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Gynecological Progestin Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Teva Generics
Besins Healthcare
Virtus Pharmaceuticals, LLC
BionPharma
Aquatic Remedies
Zhejiang Xianju Pharmaceutical
Zhejiang Aisheng Pharmaceutical
Zhejiang Medicine
Hubei Dongxin Pharmaceutical
Tianjin Jinyao Pharmaceutical
Guangzhou Baiyunshan Mingxing Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gynecological Progestin Drugs, market overview.
Chapter 2: Global Gynecological Progestin Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Gynecological Progestin Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gynecological Progestin Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gynecological Progestin Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gynecological Progestin Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gynecological Progestin Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gynecological Progestin Drugs Overall Market Size
2.1 Global Gynecological Progestin Drugs Market Size: 2022 VS 2029
2.2 Global Gynecological Progestin Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Gynecological Progestin Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Gynecological Progestin Drugs Players in Global Market
3.2 Top Global Gynecological Progestin Drugs Companies Ranked by Revenue
3.3 Global Gynecological Progestin Drugs Revenue by Companies
3.4 Global Gynecological Progestin Drugs Sales by Companies
3.5 Global Gynecological Progestin Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Gynecological Progestin Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Gynecological Progestin Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gynecological Progestin Drugs Players in Global Market
3.8.1 List of Global Tier 1 Gynecological Progestin Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Gynecological Progestin Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Gynecological Progestin Drugs Market Size Markets, 2022 & 2029
4.1.2 Progesterone
4.1.3 Dydrogesterone
4.1.4 Others
4.2 By Type - Global Gynecological Progestin Drugs Revenue & Forecasts
4.2.1 By Type - Global Gynecological Progestin Drugs Revenue, 2018-2023
4.2.2 By Type - Global Gynecological Progestin Drugs Revenue, 2024-2029
4.2.3 By Type - Global Gynecological Progestin Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Gynecological Progestin Drugs Sales & Forecasts
4.3.1 By Type - Global Gynecological Progestin Drugs Sales, 2018-2023
4.3.2 By Type - Global Gynecological Progestin Drugs Sales, 2024-2029
4.3.3 By Type - Global Gynecological Progestin Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Gynecological Progestin Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gynecological Progestin Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Gynecological Progestin Drugs Revenue & Forecasts
5.2.1 By Application - Global Gynecological Progestin Drugs Revenue, 2018-2023
5.2.2 By Application - Global Gynecological Progestin Drugs Revenue, 2024-2029
5.2.3 By Application - Global Gynecological Progestin Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Gynecological Progestin Drugs Sales & Forecasts
5.3.1 By Application - Global Gynecological Progestin Drugs Sales, 2018-2023
5.3.2 By Application - Global Gynecological Progestin Drugs Sales, 2024-2029
5.3.3 By Application - Global Gynecological Progestin Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Gynecological Progestin Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Gynecological Progestin Drugs Market Size, 2022 & 2029
6.2 By Region - Global Gynecological Progestin Drugs Revenue & Forecasts
6.2.1 By Region - Global Gynecological Progestin Drugs Revenue, 2018-2023
6.2.2 By Region - Global Gynecological Progestin Drugs Revenue, 2024-2029
6.2.3 By Region - Global Gynecological Progestin Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Gynecological Progestin Drugs Sales & Forecasts
6.3.1 By Region - Global Gynecological Progestin Drugs Sales, 2018-2023
6.3.2 By Region - Global Gynecological Progestin Drugs Sales, 2024-2029
6.3.3 By Region - Global Gynecological Progestin Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Gynecological Progestin Drugs Revenue, 2018-2029
6.4.2 By Country - North America Gynecological Progestin Drugs Sales, 2018-2029
6.4.3 US Gynecological Progestin Drugs Market Size, 2018-2029
6.4.4 Canada Gynecological Progestin Drugs Market Size, 2018-2029
6.4.5 Mexico Gynecological Progestin Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Gynecological Progestin Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Gynecological Progestin Drugs Sales, 2018-2029
6.5.3 Germany Gynecological Progestin Drugs Market Size, 2018-2029
6.5.4 France Gynecological Progestin Drugs Market Size, 2018-2029
6.5.5 U.K. Gynecological Progestin Drugs Market Size, 2018-2029
6.5.6 Italy Gynecological Progestin Drugs Market Size, 2018-2029
6.5.7 Russia Gynecological Progestin Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Gynecological Progestin Drugs Market Size, 2018-2029
6.5.9 Benelux Gynecological Progestin Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Gynecological Progestin Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Gynecological Progestin Drugs Sales, 2018-2029
6.6.3 China Gynecological Progestin Drugs Market Size, 2018-2029
6.6.4 Japan Gynecological Progestin Drugs Market Size, 2018-2029
6.6.5 South Korea Gynecological Progestin Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Gynecological Progestin Drugs Market Size, 2018-2029
6.6.7 India Gynecological Progestin Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Gynecological Progestin Drugs Revenue, 2018-2029
6.7.2 By Country - South America Gynecological Progestin Drugs Sales, 2018-2029
6.7.3 Brazil Gynecological Progestin Drugs Market Size, 2018-2029
6.7.4 Argentina Gynecological Progestin Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gynecological Progestin Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Gynecological Progestin Drugs Sales, 2018-2029
6.8.3 Turkey Gynecological Progestin Drugs Market Size, 2018-2029
6.8.4 Israel Gynecological Progestin Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Gynecological Progestin Drugs Market Size, 2018-2029
6.8.6 UAE Gynecological Progestin Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Gynecological Progestin Drugs Major Product Offerings
7.1.4 Merck Gynecological Progestin Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Teva Generics
7.2.1 Teva Generics Company Summary
7.2.2 Teva Generics Business Overview
7.2.3 Teva Generics Gynecological Progestin Drugs Major Product Offerings
7.2.4 Teva Generics Gynecological Progestin Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Teva Generics Key News & Latest Developments
7.3 Besins Healthcare
7.3.1 Besins Healthcare Company Summary
7.3.2 Besins Healthcare Business Overview
7.3.3 Besins Healthcare Gynecological Progestin Drugs Major Product Offerings
7.3.4 Besins Healthcare Gynecological Progestin Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Besins Healthcare Key News & Latest Developments
7.4 Virtus Pharmaceuticals, LLC
7.4.1 Virtus Pharmaceuticals, LLC Company Summary
7.4.2 Virtus Pharmaceuticals, LLC Business Overview
7.4.3 Virtus Pharmaceuticals, LLC Gynecological Progestin Drugs Major Product Offerings
7.4.4 Virtus Pharmaceuticals, LLC Gynecological Progestin Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Virtus Pharmaceuticals, LLC Key News & Latest Developments
7.5 BionPharma
7.5.1 BionPharma Company Summary
7.5.2 BionPharma Business Overview
7.5.3 BionPharma Gynecological Progestin Drugs Major Product Offerings
7.5.4 BionPharma Gynecological Progestin Drugs Sales and Revenue in Global (2018-2023)
7.5.5 BionPharma Key News & Latest Developments
7.6 Aquatic Remedies
7.6.1 Aquatic Remedies Company Summary
7.6.2 Aquatic Remedies Business Overview
7.6.3 Aquatic Remedies Gynecological Progestin Drugs Major Product Offerings
7.6.4 Aquatic Remedies Gynecological Progestin Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Aquatic Remedies Key News & Latest Developments
7.7 Zhejiang Xianju Pharmaceutical
7.7.1 Zhejiang Xianju Pharmaceutical Company Summary
7.7.2 Zhejiang Xianju Pharmaceutical Business Overview
7.7.3 Zhejiang Xianju Pharmaceutical Gynecological Progestin Drugs Major Product Offerings
7.7.4 Zhejiang Xianju Pharmaceutical Gynecological Progestin Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Zhejiang Xianju Pharmaceutical Key News & Latest Developments
7.8 Zhejiang Aisheng Pharmaceutical
7.8.1 Zhejiang Aisheng Pharmaceutical Company Summary
7.8.2 Zhejiang Aisheng Pharmaceutical Business Overview
7.8.3 Zhejiang Aisheng Pharmaceutical Gynecological Progestin Drugs Major Product Offerings
7.8.4 Zhejiang Aisheng Pharmaceutical Gynecological Progestin Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Zhejiang Aisheng Pharmaceutical Key News & Latest Developments
7.9 Zhejiang Medicine
7.9.1 Zhejiang Medicine Company Summary
7.9.2 Zhejiang Medicine Business Overview
7.9.3 Zhejiang Medicine Gynecological Progestin Drugs Major Product Offerings
7.9.4 Zhejiang Medicine Gynecological Progestin Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Zhejiang Medicine Key News & Latest Developments
7.10 Hubei Dongxin Pharmaceutical
7.10.1 Hubei Dongxin Pharmaceutical Company Summary
7.10.2 Hubei Dongxin Pharmaceutical Business Overview
7.10.3 Hubei Dongxin Pharmaceutical Gynecological Progestin Drugs Major Product Offerings
7.10.4 Hubei Dongxin Pharmaceutical Gynecological Progestin Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Hubei Dongxin Pharmaceutical Key News & Latest Developments
7.11 Tianjin Jinyao Pharmaceutical
7.11.1 Tianjin Jinyao Pharmaceutical Company Summary
7.11.2 Tianjin Jinyao Pharmaceutical Gynecological Progestin Drugs Business Overview
7.11.3 Tianjin Jinyao Pharmaceutical Gynecological Progestin Drugs Major Product Offerings
7.11.4 Tianjin Jinyao Pharmaceutical Gynecological Progestin Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Tianjin Jinyao Pharmaceutical Key News & Latest Developments
7.12 Guangzhou Baiyunshan Mingxing Pharmaceutical
7.12.1 Guangzhou Baiyunshan Mingxing Pharmaceutical Company Summary
7.12.2 Guangzhou Baiyunshan Mingxing Pharmaceutical Gynecological Progestin Drugs Business Overview
7.12.3 Guangzhou Baiyunshan Mingxing Pharmaceutical Gynecological Progestin Drugs Major Product Offerings
7.12.4 Guangzhou Baiyunshan Mingxing Pharmaceutical Gynecological Progestin Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Guangzhou Baiyunshan Mingxing Pharmaceutical Key News & Latest Developments
8 Global Gynecological Progestin Drugs Production Capacity, Analysis
8.1 Global Gynecological Progestin Drugs Production Capacity, 2018-2029
8.2 Gynecological Progestin Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Gynecological Progestin Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gynecological Progestin Drugs Supply Chain Analysis
10.1 Gynecological Progestin Drugs Industry Value Chain
10.2 Gynecological Progestin Drugs Upstream Market
10.3 Gynecological Progestin Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gynecological Progestin Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Gynecological Progestin Drugs in Global Market
Table 2. Top Gynecological Progestin Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Gynecological Progestin Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Gynecological Progestin Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Gynecological Progestin Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Gynecological Progestin Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Gynecological Progestin Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Gynecological Progestin Drugs Product Type
Table 9. List of Global Tier 1 Gynecological Progestin Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gynecological Progestin Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gynecological Progestin Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Gynecological Progestin Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Gynecological Progestin Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Gynecological Progestin Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Gynecological Progestin Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Gynecological Progestin Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Gynecological Progestin Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Gynecological Progestin Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Gynecological Progestin Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Gynecological Progestin Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Gynecological Progestin Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Gynecological Progestin Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Gynecological Progestin Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Gynecological Progestin Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Gynecological Progestin Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Gynecological Progestin Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Gynecological Progestin Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Gynecological Progestin Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Gynecological Progestin Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Gynecological Progestin Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Gynecological Progestin Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Gynecological Progestin Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Gynecological Progestin Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Gynecological Progestin Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Gynecological Progestin Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Gynecological Progestin Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Gynecological Progestin Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Gynecological Progestin Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Gynecological Progestin Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Gynecological Progestin Drugs Sales, (K Units), 2024-2029
Table 46. Merck Company Summary
Table 47. Merck Gynecological Progestin Drugs Product Offerings
Table 48. Merck Gynecological Progestin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. Teva Generics Company Summary
Table 51. Teva Generics Gynecological Progestin Drugs Product Offerings
Table 52. Teva Generics Gynecological Progestin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Teva Generics Key News & Latest Developments
Table 54. Besins Healthcare Company Summary
Table 55. Besins Healthcare Gynecological Progestin Drugs Product Offerings
Table 56. Besins Healthcare Gynecological Progestin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Besins Healthcare Key News & Latest Developments
Table 58. Virtus Pharmaceuticals, LLC Company Summary
Table 59. Virtus Pharmaceuticals, LLC Gynecological Progestin Drugs Product Offerings
Table 60. Virtus Pharmaceuticals, LLC Gynecological Progestin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Virtus Pharmaceuticals, LLC Key News & Latest Developments
Table 62. BionPharma Company Summary
Table 63. BionPharma Gynecological Progestin Drugs Product Offerings
Table 64. BionPharma Gynecological Progestin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. BionPharma Key News & Latest Developments
Table 66. Aquatic Remedies Company Summary
Table 67. Aquatic Remedies Gynecological Progestin Drugs Product Offerings
Table 68. Aquatic Remedies Gynecological Progestin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Aquatic Remedies Key News & Latest Developments
Table 70. Zhejiang Xianju Pharmaceutical Company Summary
Table 71. Zhejiang Xianju Pharmaceutical Gynecological Progestin Drugs Product Offerings
Table 72. Zhejiang Xianju Pharmaceutical Gynecological Progestin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Zhejiang Xianju Pharmaceutical Key News & Latest Developments
Table 74. Zhejiang Aisheng Pharmaceutical Company Summary
Table 75. Zhejiang Aisheng Pharmaceutical Gynecological Progestin Drugs Product Offerings
Table 76. Zhejiang Aisheng Pharmaceutical Gynecological Progestin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Zhejiang Aisheng Pharmaceutical Key News & Latest Developments
Table 78. Zhejiang Medicine Company Summary
Table 79. Zhejiang Medicine Gynecological Progestin Drugs Product Offerings
Table 80. Zhejiang Medicine Gynecological Progestin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Zhejiang Medicine Key News & Latest Developments
Table 82. Hubei Dongxin Pharmaceutical Company Summary
Table 83. Hubei Dongxin Pharmaceutical Gynecological Progestin Drugs Product Offerings
Table 84. Hubei Dongxin Pharmaceutical Gynecological Progestin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Hubei Dongxin Pharmaceutical Key News & Latest Developments
Table 86. Tianjin Jinyao Pharmaceutical Company Summary
Table 87. Tianjin Jinyao Pharmaceutical Gynecological Progestin Drugs Product Offerings
Table 88. Tianjin Jinyao Pharmaceutical Gynecological Progestin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Tianjin Jinyao Pharmaceutical Key News & Latest Developments
Table 90. Guangzhou Baiyunshan Mingxing Pharmaceutical Company Summary
Table 91. Guangzhou Baiyunshan Mingxing Pharmaceutical Gynecological Progestin Drugs Product Offerings
Table 92. Guangzhou Baiyunshan Mingxing Pharmaceutical Gynecological Progestin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Guangzhou Baiyunshan Mingxing Pharmaceutical Key News & Latest Developments
Table 94. Gynecological Progestin Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 95. Global Gynecological Progestin Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Gynecological Progestin Drugs Production by Region, 2018-2023 (K Units)
Table 97. Global Gynecological Progestin Drugs Production by Region, 2024-2029 (K Units)
Table 98. Gynecological Progestin Drugs Market Opportunities & Trends in Global Market
Table 99. Gynecological Progestin Drugs Market Drivers in Global Market
Table 100. Gynecological Progestin Drugs Market Restraints in Global Market
Table 101. Gynecological Progestin Drugs Raw Materials
Table 102. Gynecological Progestin Drugs Raw Materials Suppliers in Global Market
Table 103. Typical Gynecological Progestin Drugs Downstream
Table 104. Gynecological Progestin Drugs Downstream Clients in Global Market
Table 105. Gynecological Progestin Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Gynecological Progestin Drugs Segment by Type in 2022
Figure 2. Gynecological Progestin Drugs Segment by Application in 2022
Figure 3. Global Gynecological Progestin Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gynecological Progestin Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gynecological Progestin Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Gynecological Progestin Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Gynecological Progestin Drugs Revenue in 2022
Figure 9. By Type - Global Gynecological Progestin Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Gynecological Progestin Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Gynecological Progestin Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Gynecological Progestin Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Gynecological Progestin Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Gynecological Progestin Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Gynecological Progestin Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Gynecological Progestin Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Gynecological Progestin Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Gynecological Progestin Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Gynecological Progestin Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Gynecological Progestin Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Gynecological Progestin Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Gynecological Progestin Drugs Sales Market Share, 2018-2029
Figure 23. US Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Gynecological Progestin Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Gynecological Progestin Drugs Sales Market Share, 2018-2029
Figure 28. Germany Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Gynecological Progestin Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Gynecological Progestin Drugs Sales Market Share, 2018-2029
Figure 37. China Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Gynecological Progestin Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Gynecological Progestin Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Gynecological Progestin Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Gynecological Progestin Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Gynecological Progestin Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Gynecological Progestin Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Gynecological Progestin Drugs by Region, 2022 VS 2029
Figure 54. Gynecological Progestin Drugs Industry Value Chain
Figure 55. Marketing Channels
